Early studies suggested that estrogen receptor alpha (ERa) is involved in estrogen-mediated imprinting effects in prostate development. We recently reported a more complete ERa knockout (KO) mouse model via mating b-actin Cre transgenic mice with floxed ERa mice. These ACTB-ERaKO male mice showed defects in prostatic branching morphogenesis, which demonstrates that ERa is necessary to maintain proliferative events in the prostate. However, within which prostate cell type ERa exerts those important functions remains to be elucidated. To address this, we have bred floxed ERa mice with either fibroblast-specific protein (FSP)-Cre or probasin-Cre transgenic mice to generate a mouse model that has deleted ERa gene in either stromal fibroblast (FSP-ERaKO) or epithelial (pes-ERaKO) prostate cells. We found that circulating testosterone and fertility were not altered in FSP-ERaKO and pes-ERaKO male mice. Prostates of FSP-ERaKO mice have less branching morphogenesis compared to that of wild-type littermates. Further analyses indicated that loss of stromal ERa leads to increased stromal apoptosis, reduced expression of insulin-like growth factor-1 (IGF-1) and FGF10, and increased expression of BMP4. Collectively, we have established the first in vivo prostate stromal and epithelial selective ERaKO mouse models and the results from these mice indicated that stromal fibroblast ERa plays important roles in prostatic branching morphogenesis via a paracrine fashion. Selective deletion of the ERa gene in mouse prostate epithelial cells by probasin-Cre does not affect the regular prostate development and homeostasis.
INTRODUCTION
Prostate growth and development are primarily controlled by androgens. During prostatic development, in the presence of androgens/androgen receptor (AR), 1 the urogenital mesenchyme (UGM) directs prostatic epithelial budding and branching morphogenesis through interactions between the urogenital sinus epithelium and UGM. 2 Conversely, the developing prostatic epithelium induces fibroblasts to undergo smooth muscle differentiation. 3 In addition to androgens, the prostate can also respond to the stimulation of estrogens. [4] [5] [6] Lower doses of estrogens have been reported to increase prostate weight and prostatic budding. 5, 6 In contrast, higher doses of estrogens permanently suppress the neonatal rat or mouse prostate growth and prostatic branching morphogenesis by reducing testosterone (T) production, suppressing AR expression, and inducing prostatic epithelial regression. [7] [8] [9] [10] Estrogen's actions can be mediated by estrogen receptor alpha (ERa) and ERb, 11, 12 encoded by two distinct genes. Studies conducted with conventional neomycin (Neo) gene knockin and ER knockout (KO) mice suggested that ERa, but not ERb, acts as a dominant receptor of estrogen signaling in males for the development of prostate and for maintenance of normal reproductive functions. [13] [14] [15] [16] However, it remains unclear how ERa functions in different types of prostate cells to affect prostate development. Stromal-epithelial recombination experiments were used to determine ERa functions in stromal vs. epithelial cells. But, there are two major concerns with results obtained from those tissue recombinant experiments: (i) the stromal and epithelial cells used for the recombination experiment may not represent the prostate cell origins; and (ii) the recombinant is implanted under the renal capsule of immunedeficient mouse for a short period of time. Therefore, those experiments may not completely recapitulate the in vivo ERa roles in prostate developments. To resolve those potential pitfalls, floxed ERa mice were produced using a self-excising ACN (tACE-Cre/Neo) cassette. 17 We successfully produced the total ERaKO mice by mating floxed ERa mice with b-actin-Cre mice (ACTB-ERaKO), and proved that deletion of the floxed exon 3 allele can disrupt the reading frame of the ERa transcript resulting in undetectable ERa protein. 17 Studies of ACTB-ERaKO male mice demonstrated that ERa is required for maintaining male fertility, prostatic branching morphogenesis and the homeostasis of the prostate. 18 The mature prostate consists of various cell types including luminal epithelial, basal epithelial, neuroendocrine, smooth muscle, fibroblast, vascular endothelial cells, etc. In the rodent prostate, ERa is detectable in both epithelial and stromal cells. 16, [19] [20] [21] To date, several studies focused on ERa roles in high-dose estrogen-mediated squamous metaplasia (SQM) and carcinogenesis. 20, 22, 23 However, no in vivo model has effectively evaluated the roles of epithelial vs. stromal fibroblast ERa during normal prostate development. The establishment of the floxed ERa mouse model allows us to selectively delete the ERa gene in a tissue-or temporalspecific manner by breeding with transgenic mice harboring promoter specific Cre. 18 We now report the generation of the first mouse model that has floxed ERa gene selectively knocked out in stromal fibroblast cells via breeding with fibroblast-specific protein 1-Cre (FSP-Cre) or in epithelial cells via breeding with prostate epithelial-specific probasin-Cre (pes-Cre) to dissect the stromal vs. epithelial ERa function. Our in vivo tissue-selective ERaKO mouse models demonstrate that stromal fibroblast ERa plays an important role in prostatic branching morphogenesis via a paracrine-regulatory fashion.
MATERIALS AND METHODS

Generation of tissue selective ERaKO Mice
To generate FSP-Cre/ERa fl/fl and pes-Cre/ERa fl/fl mice (FSP-ERaKO and pes-ERaKO), we mated floxed ERa homozygous female mice 17 with FSP-Cre and probasin-Cre transgenic male mice, respectively. FSP-Cre mice were received from Drs H. L. Moses and N. A. Bhowmick (Vanderbilt-Ingram Cancer Center, Nashville, TN, USA) and the probasin-Cre mice were obtained from National Cancer Institute (Bethesda, MD, USA). ERa fl/fl mice were created through a collaboration with Dr S. Radovick and Dr A. Wolf (Johns Hopkins University, Baltimore, MD, USA). 17, 18 After two generations of mating, FSP-ERaKO ( Figure 1a ) and pes-ERaKO (Figure 4a ) mice were developed. Genomic DNA was isolated from tail biopsies and used as a template for PCR genotyping. Genotyping and primers were listed in our previously publications. 17, 18 The Rosa26r reporter mice have the lacZ gene inserted into the ubiquitously expressed Rosa locus. This locus is preceded by a transcriptional stop cassette flanked by two loxP sites. When Cre-recombinase is expressed, b-Gal activity can be observed in target organs. 23, 24 We bred Rosa26r-FSP-Cre compound mice to detect the Cre activity and expression pattern of FSP-Cre mice. The ACTB-ERaKO, a whole-body ERaKO, mice were generated by breeding flox ERa mice with b-actin-Cre mice as previously described. 17, 18 All animal procedures were approved by the Animal Care and Use Committee of the University of Rochester Medical Center, in accordance with National Institutes of Health guidelines.
Tissue dissection and prostatic ductal tip count Mice were first anesthetized to collect serum for hormone analysis and then killed by CO 2 asphyxiation. After centrifugation, the serum was frozen at 270 uC until assayed. The genital tracts of the animals were exposed by a lower abdominal incision. The individual organs were then microdissected, weighed, photographed and frozen for further analysis, or fixed in formalin for subsequent histological examination. For the ductal tip count experiment, microdissected ventral prostate (VP), dorso-lateral prostate (DLP) and anterior prostate (AP) were incubated in Hank's buffer containing 1% collagenase at 37 uC for 1 h to digest and remove stromal compartment. The number of ductal tips was then counted under a dissecting microscope.
Hormone radioimmunoassay
All male mice were housed individually for 1 week before collection of serum for hormone analysis. Serum T was determined using a T double antibody radioimmunoassay kit (Diagnostic System Laboratories, Inc., Webster, TX, USA). The lowest detectable T concentration is 2.0 pg ml 21 . Animals used in the hormone studies were approximately 3 months of age.
Sperm counting
The mouse epididymides were chopped into small pieces in 1.5 ml RPMI media, incubated for 40 min at 37 uC to release the sperm, and then diluted for counting the total sperm numbers per epididymis.
Immunohistochemistry (IHC), immunofluorescent staining and terminal transferase-mediated DNA end labeling (TUNEL) assay IHC and immunofluorescent staining were carried out as described previously. 17, 18 Sections were incubated with the following antibodies and dilutions: anti-b-gal antibody (40-1A, 1 : 400), anti-ERa (MC-20, 1 : 400), anti-AR (N-20, 1 : 400), anti-Ki67 (NCL-Ki67p, 1 : 1000), anti-vimentin (LN-6, 1 : 200), anti-SM a-actin (1A4, 1 : 400), antidesmin (DE-U-10, 1 : 300), anti-heavy chain myosin (G-4, 1 : 500) and anti-pan-cytokeratin (H-240, 1 : 200) in phosphate buffered saline containing 3% bovine serum albumin overnight at 4 uC. For IHC, the tissue slides were incubated with 1 : 300 diluted biotinylated secondary antibody (Vector Laboratories, Burlingame, CA, USA) and ABC solution (Vector Laboratories), then stained using AEC (DAKO, Carpenteria, CA, USA). Mayer's hematoxylin was used for a nuclear counterstain. Negative controls were incubated without primary antibody. For immunofluorescent staining, the tissue slides were incubated with 1 : 100 Texas red-conjugated goat anti-mouse IgG or fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (ICN, Costa Mesa, CA, USA). Stained slides were mounted with mounting media containing 49-6-Diamidino-2-phenylindole and visualized with a fluorescent microscope. The apoptosis in paraffin embedded tissue was detected by the TUNEL assay using In situ Cell Death Detection Kit (Roche, Indianapolis, IN, USA) following the manufacturer's instructions. 49-6-Diamidino-2-phenylindole-stained cells were counted under a fluorescent microscope from at least six randomly selected fields. Cells positive for TUNEL staining were counted in the same field. At least six fields from each lobe of prostates were analyzed. The apoptotic index was determined by dividing the number of TUNEL positive cells by the total numbers of cells in all six fields.
RNA extraction and RT-PCR
Total RNA was extracted and purified using Trizol (Invitrogen, Carlsbad, CA, USA) and RT-PCR has been described previously. 18, 25 Briefly, 3 mg total RNA from wild-type (WT) or tissue-specific ERaKO prostates was subjected to reverse transcription using Superscript III (Invitrogen, Carlsbad, CA, USA). The RT-PCR was performed with first-strand cDNA, specific gene primers and SYBR Green PCR Master Mix (Biorad, Hercules, CA, USA). The Q-PCR cycle was performed as follows: 94 uC for 3 min, 40 cycles of 94 uC for 30 s, 60 uC for 30 s and 72 uC for 30 s on an iCycler iQ Multi-color RT-PCR detection system (Biorad). Primer sequences for mouse genes have been described previously. 18 The primer sequences for rat genes: FGF7, sense, 59-GCTTCCACCTCGTCTGTCTTG-39; antisense, 59-CCCTTTCACTT-TGCCTCGTTTG-39. 
Statistical analyses
Values were expressed as mean6standard deviation (s.d.). We used the t-test to compare values among the two groups. Calculated P values were two-sided, and P,0.05 was considered statistically significant.
RESULTS
Generation of FSP-ERaKO Mice
To address the role of stromal fibroblast ERa in normal prostate development, we generated mice with conditional deletion of the ERa gene in stromal fibroblast cells by mating floxed ERa female mice with male mice expressing Cre recombinase driven by the FSP1 promoter ( Figure 1a ). FSP1 gene expression is first detected by in situ hybridization at embryonic day 8.5 as a postgastrulation event, and is associated with cells of mesenchymal origin or of fibroblastic phenotype. [26] [27] [28] Selective Cre-mediated recombination exerted by the FSPCre transgene has been observed in stromal fibroblast cells throughout the mouse, including the prostate, forestomach and skin. 29 The Rosa26r reporter mice have the lacZ gene inserted into the ubiquitously expressed Rosa locus, which is preceded by a transcriptional Prostate branching morphogenesis in FSP-ERaKO mice M Chen et al 548 stop cassette flanked by two loxP sites. When Cre-recombinase is expressed, this stop cassette is deleted and b-galactosidase activity can be observed in target organs. 23, 24 We examined FSP-Cre-mediated loxP site recombination within the mouse prostates in Rosa26rFSP-Cre mice. Figure 1b showed that FSP-Cre specifically expressed in the prostatic stromal compartment with strong expression in the VP and DLP (arrows), marginal expression in the AP, and was not detectable in the prostatic epithelial cells.
To verify ERa gene deletion in the FSP-ERaKO mice, pups were genotyped for floxed ERa, WT ERa, ERaKO allele and the FSP-Cre transgene ( Figure 1c) . Deletion of ERa exon III was confirmed by detection of truncated mRNA transcripts using a pair of PCR primers located on exons II and IV of the ERa gene. Our data showed truncated ERa transcripts within the prostate, epididymis, efferent ducts and testis of the FSP-ERaKO mice (Figure 1d) .
ERa deletion in FSP-ERaKO prostates was further validated by IHC in the prostates of 1-month-old mice. We found that ERa expression was positive in epithelial cells in VPs of WT and FSPERaKO mice (Figure 1e , I, arrows). However, ERa expression was dramatically reduced in the stromal compartments of FSP-ERaKO VPs (Figure 1e , II vs. I, arrowhead) as compared to that of WT littermates.
Normal genital tract development and fertility in adult FSP-ERaKO males Comparing 3-month-old FSP-ERaKO males to WT littermates, histological analyses demonstrated that there were no phenotype alterations in the male reproductive system including testes, epididymides (Figure 2a) , or efferent ducts and seminal vesicles (data not shown). FSP-ERaKO testes consisted of compact seminiferous tubules. The atrophic and degenerating seminiferous tubules present in the ACTB-ERaKO were not observed in the FSP-ERaKO mice. 18 The FSP-ERaKO epididymis also appeared normal as compared to those of WT mice (Figure 2a) . There was no statistical difference in the epididymal sperm number count between FSP-ERaKO and WT mice (Figure 2b) . Furthermore, in contrast to the infertility of ACTBERaKO mice, when mating WT and FSP-ERaKO males with fertile B6 females, we found that there were no statistical differences in litter sizes among those matings (Figure 2c) . Moreover, the serum T level in FSP-ERaKO males is similar to the levels in WT males at 3 months of age ( Figure 2d) . Together, our data indicate that the serum T levels, the development of testes and epididymides, and male fertility remain normal in FSP-ERaKO males.
Reduced prostate branching morphogenesis and weight in FSP-ERaKO mice Our previous report 18 of the total ERaKO (ACTB-ERaKO) mice showed that ERa is involved in prostatic branching morphogenesis; however, it is unclear as to whether epithelial or stromal ERa plays a dominant role in prostatic branching morphogenesis. Results of comparing microdissected prostates from 3-monthold mice, demonstrated the reduced number of ductal tips derived from prostatic branching of adult ACTB-ERaKO prostates (Figure 3a , ACTB-ERaKO vs. WT, **P,0.001 in both VP and DLP). Compared to WT mice, FSP-ERaKO mouse prostates had a significantly reduced branching morphogenesis (Figure 3a , FSP-ERaKO vs. WT, **P,0.01 in VP; *P,0.001 in DLP). It has been known that APs, also called coagulating glands, are less similar to human prostate structure and development. Indeed, we did not observe a difference in branching morphogenesis in the APs of FSP-ERaKO and WT mice, which is consistent with results in the ACTB-ERaKO mice. 18 Consistently, we observed the reduced prostate weights in FSP-ERaKO mice (Figure 3b) . Together, our findings from FSP-ERaKO provided direct evidence that prostate fibroblast ERa plays important roles in prostatic branching morphogenesis.
Increased stromal apoptosis in the FSP-ERaKO prostates
The mouse prostate undergoes extensive branching morphogenesis and 85% of the adult number of ductal tips and branch points are formed during the first 15 days after birth, 30 suggesting that prostate cell proliferation rate is high during the neonatal stages. As we observed reduced branching morphogenesis and prostate weights in the FSP-ERaKO mice (Figure 3a and b) , we were interested in comparing the proliferation activity of the VP between FSP-ERaKO and WT mice at 1-week-old (Figure 3c) . IHC results of Ki67 expression suggested that there was no difference in either epithelial proliferation (Figure 3d, arrows) or (Figure 3d , arrowheads) between neonatal FSPERaKO and WT VPs. We also did not observe any significant proliferation difference between the adult FSP-ERaKO and WT prostates (data not shown). As there was no significant change in proliferative rate of neonatal and adult mouse prostate, we examined the apoptotic activities in the FSP-ERaKO and WT prostates. As expected, apoptosis occurred rarely in 1-week-old WT and FSP-ERaKO mouse prostates (data not shown). In adult mouse prostates, TUNEL assay indeed showed that there was a significantly increased stromal apoptosis in the FSPERaKO males (Figure 3d , III vs. I, arrowheads, VP data were shown), suggesting that the increased apoptotic rate contributed to the reduced branching morphogenesis in the FSP-ERaKO mice. The quantitative apoptotic index is shown in Figure 3e .
The expressions of AR, AR target genes and ERb are normal in the FSP-ERaKO prostates It has been known that AR and ERb could affect prostate development and homeostasis. [31] [32] [33] [34] [35] [36] Therefore, we checked whether there were changes of AR and ERb expression or functions in FSP-ERaKO prostates.
The expression of AR was detected via both IHC and Q-PCR methods. Our IHC results indicated that AR was located predominantly in the nuclei of luminal epithelial cells and there was no obvious Prostate branching morphogenesis in FSP-ERaKO mice M Chen et al 550 difference in AR expression levels or nuclear-cytosol distribution between adult FSP-ERaKO and WT VP and DLP (Figure 3g) . Consistently, Q-PCR data suggested there was no significant change of AR mRNA in the FSP-ERaKO prostates (Figure 3f) . AR target genes, PSP94 and NKX3.1, markers of prostate cytodifferentiation, also expressed normally in FSP-ERaKO prostates as compared to WT littermates (Figure 3f) . Furthermore, we did not observe any significant change in the expression of ERb in the FSP-ERaKO prostates (Figure 3f) . Together, these observations suggest that the defects of prostate ductal morphogenesis in the FSP-ERaKO prostates is not due to the alterations of serum T level (Figure 2d) , or expressions of AR, AR target genes and ERb (Figure 3f and g ).
Generation and genotyping of pes-ERaKO mice
In addition to the stromal compartment, it is argued that prostate epithelial cells also express ERa and the epithelial ERa may contribute to the prostate development. To address this, it is important to use prostate epithelial cell-specific Cre to knock out the ERa gene. The similar breeding strategy of producing FSP-ERaKO mouse was applied to generate the pes-ERaKO mice (Figure 4a ). The promoter of probasin is well characterized and widely applied in many animal models. [37] [38] [39] The expression of probasin Cre (PB-Cre) is prostatic epithelial-specific and is postnatal and gradually increased with highest expression in the lateral lobe, followed by the VP, and then the DP and AP. 37, 38 Therefore, PB-Cre can specifically knock out the floxed ERa gene in prostate epithelial cells (pes-ERaKO).
To verify ERa gene deletion in the pes-ERaKO mice, young mice were genotyped for floxed ERa allele and PB-Cre transgene (Figure 4b ). Since the Cre recombinase only expressed in the adult prostate epithelial cells, there is no ERaKO band detected in the tail snips of these pes-ERaKO mice (Figure 4b, lane 3) . In 3-month-old pes-ERaKO mice, only the prostates revealed a recombined 223-bp DNA fragment of the ERa KO allele (Figure 4c, lane 4) , indicating that PB-Cre selectively disrupts ERa in the prostates.
Although ERa protein expression is elevated in VP and DLP lobes in prostate cancer, or in estrogen-stimulated prostate proliferation and SQM, we and other investigators have found that ERa protein can be detected in VP and DLP, with a more stronger expression in AP of mice prior to any development of prostate diseases. Therefore, we compared the ERa expression in the AP of adult pes-ERaKO and WT littermates. ERa was mainly detected in the AP epithelial cells of WT mice (Figure 4d, left panel) and was rarely detected in pesERaKO AP (Figure 4d, right panel) , which indicates that ERa is selectively ablated in pes-ERaKO prostate epithelial cells.
Genital tract phenotype, fertility and prostatic branching morphogenesis in adult pes-ERaKO males Similar to FSP-ERaKO males, 3-month-old pes-ERaKO males did not exhibit any abnormalities in terms of the genital tract, sperm number and fertility (Figure 5a-c) , suggesting that a postnatal depletion of epithelial ERa in the prostates did not affect the male reproductive system or fertility. Furthermore, pes-ERaKO prostates did not display any difference in weight and branching morphogenesis when compared to WT prostates (Figure 5d and e) . Consistently, there was no significant changes in the expression of genes involved in prostatic branching morphogenesis (BMP4, BMP7 and Shh), prostatic cytodifferentiation markers (PSP94 and NKX3.1), or smooth muscle marker (SM-a-actin) between 3-month-old pes-ERaKO and WT prostates (Figure 5f ). Further comparison between pes-ERaKO and WT prostates was conducted on 12-month-old mice, since PB-Cre efficiency is believed to reach 100% at that age. 38 Comparisons revealed that pes-ERaKO and WT prostates have similar gene expression profiles and branching morphogenesis (data not shown). Taken together, our findings suggest that stromal ERa, but not epithelial ERa, is involved in prostatic branching morphogenesis and homeostasis of prostate.
Gene profile comparison in the WT, FSP-ERaKO and pes-ERaKO prostates
The prostatic branching morphogenesis is a complex interaction between prostate epithelial and mesenchymal cells regulated by time-specific and region-specific expression of signaling molecules. 40 Our previous studies found selective upregulation of BMP4 expression, 
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but not BMP7, in the ACTB-ERaKO prostates. 18 As BMP4 is a mesenchymal factor that inhibits prostatic branching morphogenesis, 41 the upregulation of BMP4 in the ACTB-ERaKO prostates could directly contribute to the reduced branching morphogenesis. 18 As the reduced branching morphogenesis is also observed in the FSP-ERaKO mice, we were interested in determining whether BMP4 and other paracrine factors are regulated by prostate stromal ERa to influence branching morphogenesis. We examined the expression of several important genes involved in prostatic branching morphogenesis, including sonic hedgehog (Shh), the fibroblast growth factor (FGF) family, insulin-like growth factor-1 (IGF-1), and the bone morphogenesis protein (BMP) family by RT Q-PCR. Our results showed that loss of stromal ERa in the mouse prostate leads to reduced expression of IGF-1, and increased expression of BMP4 in the VP of FSP-ERaKO ( Figure 6a , *P,0.05). There are no significant changes in the expression of Shh, FGF7, FGF10 or BMP7, known to inhibit branching morphogenesis in the prostate. 42 In the pes-ERaKO, expression levels of these genes showed no significant difference. We also observed that expression of IGF-1 decreases and BMP4 increases in the DLP of FSP-ERaKO (Figure 6b) . Furthermore, FGF10 is reduced in DLPs of FSP-ERaKO as compared to those of pes-ERaKO and WT. However, we found IGF-1 and FGF7 expressions are slightly higher in the DLP of pes-ERaKO as compared to that of FSP-ERaKO. The slightly increased IGF-1 and FGF7 expressions may compensate for the BMP4 growth inhibition effects in the prostates of pes-ERaKO mice. Together, our data suggested that there is a slightly different cytokine growth factor profile in the VP and DLP of ERaKO mice.
Collectively, the prostate branching morphogenesis can be regulated by inhibiting factors, such as BMP4, as well as promoting factors including IGF-1 and FGF10. The current studies demonstrate that loss of stromal fibroblast ERa could alter the expression of important stromal factors that are involved in prostatic branching morphogenesis, and our results also suggest that stromal fibroblast ERa acts through a paracrine mechanism to regulate prostatic branching morphogenesis.
DISCUSSION
The prostate is a glandular structure consisting of epithelial and stromal compartments. A growing body of evidence has suggested that Prostate branching morphogenesis in FSP-ERaKO mice M Chen et al 552 estrogen signaling exerts a direct impact on prostate pathogenesis and cancer. 18, 21, 43, 44 Previous studies from conventional ER KO mice revealed that ERa, not ERb, is the critical receptor to mediate the estrogens response in those processes. 7, 8, 19, 21 To investigate the in vivo roles of ERb in mouse prostate development, the neo-ERbKO mouse model was applied. The neo-ERbKO male mice from Chapel Hill revealed a hyperplastic prostate, 13 while the same transgenic mice housed at Karolinska Institute presented with prostatic intraepithelial neoplasia. 35 However, those phenotypes were not generally observed in the similar neo-ERb mice generated by other groups. 45 Recently, a new and improved ERbKO mouse model has been developed in which exon III of the ERb gene was deleted by Cre-loxP mediated excision and was devoid of any transcript downstream of exon III. 46 The studies using the Cre-loxP ERbKO mouse model showed that ERb is not required for the development and homeostasis of the major body systems including the prostate, which further confirmed the important role of ERa, not ERb, in the estrogen-mediated response in the prostate.
FSP-Cre-mediated excision of ERa could occur in multiple reproductive organs prenatally including the testes and epididymides (Figure 1d) . Therefore, we examined whether there is any abnormality of fertility in the FSP-ERaKO. Compared to ACTB-ERaKO males, FSP-ERaKO males are fertile with normal development of testes and epididymides and serum T levels, which suggested that a prenatal deletion of stromal fibroblast ERa in the male reproductive organs does not affect male fertility. We also further delineated that loss of stromal fibroblast ERa in the mouse prostate glands resulted in reduced branching morphogenesis in FSP-ERaKO mice. FSP-Cre cannot completely knock out ERa in the stromal cells, and currently, there is no perfect stromal Cre mouse model available. However, FSP-Cre is known to knock down 50%-65% of floxed target genes in the mouse prostate, 44 which has been widely used to knock out a variety of target genes. 30, 47 It is well documented that a low dose of estrogen can increase AR expression, prostate weight and prostatic budding in the rodent prostates, 48, 49 which suggested that the physiological range of estrogens via ERs might promote prostatic branching morphogenesis and is consistent with our current studies that either loss of ERa in whole body 18 or only in stromal cells inhibit branching morphogenesis in the rodent prostates. It is well known that there are endogenous estrogens in males. Fat cells can produce estrogen, T can be converted to E2 and DHEA can be converted by 17b DSH-1 to estrogenic compounds. 50 Therefore, results comparing WT, pesERaKO and FSP-ERaKO male prostates have provided the in vivo evidence that stromal ERa is important to regulate prostate branching morphogenesis. In addition, the high dose of estrogen will induce estrogen imprinting effect in neonatal prostate and SQM in the adult rodent prostates. We have recently published the characterization of the response of tissue-specific ERaKO prostates to high doses of estrogen. 44 From our studies, we found that in response to estrogen, FSP-ERaKO prostates develop a full and uniform SQM, In contrast, loss of epithelial ERa inhibits estrogen-mediated SQM evidenced by significantly decreased CK10 positive squamous cell stratification and differentiation, reduced upregulation of ERa expression, and the presence of normal proliferative activities in the estrogen-treated pesERaKO prostates. Together, these in vivo results suggest that stromal ERa is responsible for prostate branching morphogenesis and epithelial ERa is required for estrogen-mediated proliferative response and SQM development. Moreover, the branching morphogenesis observed between WT and FSP-ERaKO was significantly different. Our results indicated that phenotype changes are observed in VP and DLP, but not AP. The major reason may be that FSP-Cre was specifically expressed in the prostatic stromal fibroblast cells with strong expression in VP and DLP compared to AP (Figure 1b) . Although the resulting phenotypes of arrested branching morphogenesis are similar to ACTB-ERaKO, the current study provides direct evidence that loss of ERa in the stromal fibroblast cells, but not in epithelial cells, of prostate reduces the formation of prostatic ductal tips and impairs branching morphogenesis. Moreover, in addition to BMP4 regulation of ERa, we also found that IGF-1 can be regulated by ERa in prostate fibroblast cells of intact mice in vivo and in primary cultured rUGM cells in vitro. Those stromal factors are specifically regulated by ERa, because genes in the same family, such as FGF7 and FGF10, or other stromal factors are not affected by loss of stromal fibroblast ERa in the mouse prostate. IGF-1 has been considered as a growth factor and is well suited to act as a paracrine factor to Figure 6 The genes regulated by stromal ERa in mouse prostate. Comparison of the expression levels of the genes involved in prostatic branching morphogenesis between FSP-ERaKO, pes-ERaKO and WT littermates by RT-PCR. Assays were performed on RNA from the VP (a) and DLP (b) of individual mouse and then averaged for the gene expression. *P,0.05 vs. WT littermates (n54, statistically significant by unpaired t-test). b-actin was used as internal control. DLP, dorso-lateral prostate; ER, estrogen receptor; FSP, fibroblast-specific protein; IHC, immunohistochemistry; KO, knockout; pes-ERaKO, prostate epithelial cellspecific ERaKO; RT-PCR, real-time PCR; VP, ventral prostate; WT, wild type.
Prostate branching morphogenesis in FSP-ERaKO mice M Chen et al 553 modulate mesenchymal-epithelial interaction in the prostate. The important roles of IGF-1 in normal prostate is revealed by the recent report that grafted prostatic tissue from IGF-1 KO and IGF-1R KO mice have retarded prostatic growth relative to grafts of normal urogenital sinus. 51 Our current studies emphasized IGF-1 could be involved in the prostatic development as a downstream gene regulated by stromal estrogen signaling in the prostate. Further studies are needed to determine the mechanism by which ERa regulates IGF-1 expression.
Our previous studies found that proliferation of prostate stromal cells was significantly reduced in ACTB-ERaKO mice at 1-week-old, which could partly contribute to the reduced branching in the ACTBERaKO prostates. 18 Interestingly, we did not observe any significant changes of proliferation rate in prostate epithelial and stromal cells of FSP-ERaKO compared to WT mice at 1-week-old (Figure 3b) . Instead, we observed that the apoptotic index of FSP-ERaKO prostates was significantly higher than WT prostates (Figure 3c and d) . The phenotypic difference in the prostates of ACTB-ERaKO and FSPERaKO mice suggested that ERa in stromal compartments may exert tissue or cell type-specific function and be involved in the prostatic stromal cell survival.
Probasin-Cre-mediated excision of ERa is highly specific in the prostatic epithelial cells ( Figure 5c ). As expected, pes-ERaKO males develop with normal fertility due to restricted Cre expression in prostatic epithelial cells. In contrast to FSP-ERaKO mice, the pes-ERaKO males develop normal prostates with normal ductal morphogenesis. The results suggest that postnatal deletion of epithelial ERa by probasin-Cre will not affect prostate homeostasis from fetal to adult stage. It has been well known that the mouse prostate undergoes extensive branching morphogenesis during the first 15 days of life. 30 Probasin promoter-driven Cre excision is barely detectable in the prostate during the first 15 days of neonatal mice, 37 which could be the reason that we did not observe the changes in the pes-ERaKO prostate development. In order to further define the role of epithelial ERa in the early prostatic development, the use of NKX3.1 Cre could be an ideal strategy, because its Cre activity begins to express at embryonic stage E17.5 in a prostatic epithelium-specific manner. 52 Alternatively, we could utilize other epithelial specific Cre mice, CK18-Cre and CK14-Cre, 53, 54 to disrupt the ERa gene in the mouse prostate epithilium. In addition, Omoto et al. 16 has shown that the expression of ERa is stage-dependent and its expression in the mouse prostate epithelial cells could be changed from negative to positive under different challenges, such as estrogenic compound exposure, 44 castration followed by androgen supplementation 16 and pathophysiological progression from normal prostate to benign prostatic hyperplasia or prostate cancer. Therefore, it might be necessary to combine cell type-specific and temporal control Cre activity to knock out ERa in order to fully understand the roles of stromal vs. epithelial ERa in the prostate development, as well as prostate disease progression. 55 In conclusion, we have generated prostate cell type-selective FSPERaKO and pes-ERaKO mouse models and have characterized the functions of ERa in the male genital tract and prostates using those two ERaKO mouse models. Our data support the hypothesis that ERa regulates the prostate in the context of stromal and epithelial interaction. The current studies using these tissue-specific KO mice extended our previous ACTB-ERaKO findings by validating and confirming that stromal fibroblast ERa plays an important role in prostate epithelial branching morphogenesis and prostatic homeostasis. Our study also demonstrated that there are several paracrine factors regulated by E2/ERa, and IGF-1 and BMP4 are responsible for E2/ERa signals in the prostate stromal cells.
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